Ditustat 22 mg/ml drops 50 ml
Ditustat 22 mg/ml drops 50 ml
Registered medicinal product Ditustat 22 mg/ml
Drops 50 ml
Ditustat suppresses irritating, non-productive cough in laryngitis, acute and chronic airway inflammation, pneumothorax and respiratory bleeding of various origins.
The registered medicinal product Ditustat is indicated for the treatment of:
irritant cough
- in laryngitis
- acute and chronic inflammations of the respiratory tract
- Pneumothorax
- respiratory bleeding of various origins
Dosage and method of use
Children aged 6-12 months:6 drops 3-4 times a day. Ages 1-3 years: 13 drops 3-4 times a day. Ages 3-13 years:26 drops 3-4 times a day. Teens and adults: 52 drops 3-4 times a day. Consecutive doses must not be taken earlier than 4 hours after the previous dose.
Contraindications
The product is intended for adults and children from 6 months. The drug must not be taken by pregnant and breastfeeding women and children under 6 months. Read the package insert carefully. Ditustat, Oral Drops, Solution is a medicinal product for internal use. It contains the active substance dropropizin.
Storage
Always keep the product out of sight and reach of children. Store at temperatures up to 25 °C. Do not refrigerate, protect from frost. Keep in the box to protect the product from light. Do not dispose of any medicines in wastewater or household waste. Ask your pharmacist how to dispose of products you no longer use. These measures help protect the environment.
Notice
Over-the-counter medicine. Read the full package leaflet carefully before taking this medicine.
Manufacturer's address:
Teva Pharmaceuticals CR s. r. o., Sokolovská 136/A, 180 00 Prague
Specifications
Active ingredient
Category
Form
Usage
Packaging
Storage temperature
Identifiers
Pharmacotherapeutic group
Product characteristics
| Code: | SPToth0043 |
| Warranty: | 24 months |
| Manufacturer information |
Teva Pharmaceuticals CR, s.r.o., Sokolovská 136/A, 180 00 Praha, CZ, +420548226521, [email protected] www.teva.cz |